Karyopharm Therapeutics | KPTI - Market Capitalization


Karyopharm Therapeutics reported $952.8M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Abbott USD 217.86B 15.25B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Enanta Pharmaceuticals USD 122M 98M Dec/2024
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
J&J USD 581.05B 80.81B Apr/2026
Karyopharm Therapeutics USD 652M 517M Apr/2026
MacroGenics USD 102M 4M Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Nektar Therapeutics USD 14.34B 13.48B Apr/2026
Novartis USD 292.21B 26.55B Dec/2025
Novartis USD 263.08B 17.01B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025
Tectonic Therapeutic USD 390M 96M Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Xencor USD 1.09B 256M Dec/2025